Resolian North America

  1. Home

  2. caret-right icon

    Immunoassay Solutions

  3. caret-right icon

    About Gyrolab

  4. caret-right icon

    CRO Partners

  5. caret-right icon

    Resolian North America

“The semi-automated Gyrolab® workstations provide our clients a robust immunoassay for the development, validation, and execution of biomarker, pharmacokinetics, toxicity, and immunogenicity assays for drug development.”

 

Resolian is a GxP compliant CRO with 500 employees in the USA, UK, Australia and China. Collaborating on all therapeutic modalities, Resolian fuses expertise from Alliance Pharma, Drug Development Solutions and Denali to provide worldwide access to proven scientific solutions.

Our team of immunoassay experts provide clients with reliable timely data throughout assay development, validation, and sample analysis. They also have extensive GxP training and follow the ICH M10 guidelines.

Resolian logo-green

Resolian and Gyrolab

Tim Logue, (Senior Scientist Team Lead), explains,

“Resolian has a team of over 10 dedicated specialists and analysts with two validated Gyrolab xPlore™ workstations at the US site in Malvern, PA. The automation of the Gyrolab instrument helps keep the assay results consistent over time by mitigating human error. The removal of incubation times helps reduce periods of passive binding and limits the matrix effect, thus allowing the assay to be performed in up to 50% matrix.”

 

About Resolian Immunoassay and Bioanalytical Laboratories:

As a global dedicated bioanalytical center, we are industry leaders in providing integrated bioanalytical support across all phases of drug development. Our large and flexible capacity allows us to allocate resources to match the customer’s needs, from method development projects to large, complex multi-center clinical trials. Our capabilities include:

  • Bioanalytical method development and validation in adherence to the latest industry guidance.
  • Analysis of samples in support of all phases of drug development in compliance with the regulatory requirements for GLP and GCP.
  • Services include PK, PD, immunogenicity, and flow cytometry assays which can be supported by in-house data management, statistical analysis and kits and logistics teams

To find out more, visit the Resolian website or contact BD@resolian.com.